Since the first introduction of sodium iodide I-131 for use with thyroid patients almost 80
years ago, more than 50 radiopharmaceuticals have reached the markets for a wide range …

Targeted radiation therapy (TRT) is a strategy increasingly adopted for the treatment of
different types of cancer. The urge for optimization, as stated by the European Council …

Radiopharmaceutical therapies are gaining increasing prominence as they improve survival
in patients with common diseases such as metastatic prostate cancer (1, 2). However …

The assessment of gliomas by 18F-FDOPA PET imaging as an adjunct to MRI showed high
performance by combining static and dynamic features to noninvasively predict the isocitrate …

Abstract Peptide Receptor Radionuclide Therapy (PRRT) delivers targeted radiation to
Somatostatin Receptor (SSR) expressing Neuroendocrine Neoplasms (NEN). We sought to …

Radionuclide Therapy (RNT) with 177Lu-DOTATATE targeting somatostatin receptors
(SSTRs) in neuroendocrine tumours (NET) has been successfully used in routine clinical …

The fibroblast activation protein (FAP) is heavily expressed in fibroblasts associated with the
tumor microenvironment, while the prostate-specific membrane antigen (PSMA) is …

Targeted radionuclide therapy (TRT) and immunotherapy are rapidly growing classes of
cancer treatments. Basic, translational, and clinical research are now investigating …

Background Standardized patient‐specific pretreatment dosimetry planning is mandatory in
the modern era of nuclear molecular radiotherapy, which may eventually lead to …

Purpose To evaluate the feasibility of using the StarGuide (General Electric Healthcare,
Haifa, Israel), a new generation multi-detector cadmium-zinc-telluride (CZT)-based …